liver transplant

Infections in liver and lung transplant recipients. A national prospective cohort

Infections are a major complication of solid organ transplants (SOTs). This study aimed to describe recipients' characteristics, and the frequency and etiology of infections and transplant outcome in liver and lung SOTs, and to investigate exposures associated to infection and death in liver transplant recipients. The study population included recipients of SOTs performed in Italy during a 1-year period in ten Italian lung transplant units and eight liver transplant units.

Donor liver small droplet macrovesicular steatosis is associated with reduced graft survival after liver transplantation

Modern hepatic steatosis classification includes large droplet macrovesicular (L-MaS), small droplet macrovesicular (S-MaS) and true microvesicular (MiS). Based on previous classification simply describing macrovesicular and microvesicular steatosis, donor livers with ≤30% of hepatocytes with macrosteatosis, which should represent L-MaS, are considered safe to be transplanted, while microsteatosis is usually not considered a risk factor for graft loss.

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma